Oct 19, 2015

It's Status Quo for Now: Federal Circuit Denies Petition for Rehearing En Banc in Amgen v. Sandoz

On Friday, October 16, 2015, the Federal Circuit denied the petitions for rehearing by the panel and rehearing en banc filed by both parties in Amgen v. Sandoz. Amgen petitioned for rehearing of the panel's decision holding that the information sharing provisions of the Biologics Price Competition and Innovation Act (BPCIA), namely, the disclosure of […]
back to top